Reality Check9 Jan 2019 09:00
Yourgene was a blessing after the debacle of VIY, so i do not have an axe to grind. But years of hype and hold ups alike have left us here, today.
My b/e is about 15-16p, and today the SP is between 8 & 10p on a regular basis. In the early days there was talk of 50p and then 24p.
Now that the company hasn't got the problems or the hype, this 9p SP could be the real value.
Looking at the company, Bloomberg say they employees 91. So let's say 10 that control the company, 25 that do the technical and the remainder, 46, that do normal business roles.
Operationally, in the last half year report it is stated that they did 38,000 tests. Let's say that annually they are doing 120,000 annnually now that the trouble of illumina has stopped. That's 10k a month, 2.5 a week, 500 a day. Each machine does 12. I guess here. Let's say 30mins per machine test. That's 4 machines worth. Then 25 people to do analytics, report writing etc, then a bunch of folk (46) to pack and distribute.
All this seems a bit overblown to me, unless they are expecting big numbers in the near future. Which has been the constant cry (very faintly) of jam tomorrow
The men behind all this are almost invisible. Investors get morsels, the CEO and CIO are not communicating, which is part of their job description. Other investors are trying to piece together what is going on. Thanks to them for what they have done. I am still none the wiser
So, I am hoping this business, which seems to have customers and a product and loads of people and may now be either a going concern or a M&A or a takeover, is being consistently brought to a point where it is valued at 9p a share, and the only way I will see a return is by waiting years for it to grow or merge.
This is my view based on what I have experienced over time, and with some frustration and a dollop of what I think is some reality. Please feel free to pick it to shreds